Anticorps Recombinant de lapin anti-SPR

SPR Recombinant Antibody for WB, IF/ICC, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

WB, IF/ICC, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

243138A12

N° de cat : 85796-5-PBS

Synonymes

EC:1.1.1.153, SDR38C1, Sepiapterin reductase

---

Galerie de données de validation

• 

  WB analysis using 85796-5-RR (same clone as 85796-5-PBS)

  Various lysates were subjected to SDS PAGE followed by western blot with 85796-5-RR (SPR antibody) at dilution of 1:10000 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 85796-5-PBS in a different storage buffer formulation.

• 

  IF Staining of HepG2 using 85796-5-RR (same clone as 85796-5-PBS)

  Immunofluorescent analysis of (-20°C Ethanol) fixed HepG2 cells using SPR antibody (85796-5-RR, Clone: 243138A12 ) at dilution of 1:200 and CoraLite®488-Conjugated Goat Anti-Rabbit IgG(H+L) (SA00013-2). This data was developed using the same antibody clone with 85796-5-PBS in a different storage buffer formulation.

• 

  Affinity and Kinetic Characterization of 85796-5-RR

  Biolayer interferometry (BLl) kinetic assays of 85796-5-RR against Human SPR were performed. The affinity constant is 0.855 nM.

---

Informations sur le produit

85796-5-PBS cible SPR dans les applications de WB, IF/ICC, Indirect ELISA et montre une réactivité avec des échantillons Humain

• Réactivité: Humain
• Hôte / Isotype: Lapin / IgG
• Clonalité: Recombinant
• Type: Anticorps
• Immunogène: SPR Protéine recombinante Ag10395
• Nom complet: sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)
• Masse moléculaire calculée: 261 aa, 28 kDa
• Poids moléculaire observé: 28 kDa
• Numéro d’acquisition GenBank: BC017310
• Symbole du gène: SPR
• Identification du gène (NCBI): 6697
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Purification par protéine A
• Tampon de stockage: PBS only
• Conditions de stockage: Store at -80°C. 20ul contiennent 0,1% de BSA.

{{ptg:RelatedPrimaryAntibodies}}